CompanyGraph
What stands out
- Dividend several times the last twelve months' earnings
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 1.65: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Dividend several times the last twelve months' earnings
Dividends view
Yield
1.89%Below 5Y avg (2.53%)
Annual Rate
CNY 0.10Paid annual
Payout Ratio
374.5%High
Payback Period
52.0 yr
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.41BCNY658.99M · vs all stocks (USD)
Trailing P/E
171.33xRevenue (TTM)
2.94BCNY438.36M · vs all stocks (USD)
Profit Margin
0.70%Beta
0.3340xvs all stocks
52-Week Change
-21.81%vs all stocks
Market Capitalization
4.41BCNY658.99M · vs all stocks (USD)
Enterprise Value
5.90BCNY880.31M · vs all stocks (USD)
Trailing P/E
171.33xForward P/E
17.13xPrice to Sales (TTM)
1.47xPrice to Book (MRQ)
1.71xEnterprise to Revenue
2.01xEnterprise to EBITDA
10.65xGross Margin
40.04%Profit Margin
0.70%Operating Margin
16.73%Return on Assets (TTM)
3.44%Return on Equity (TTM)
-0.54%Revenue (TTM)
2.94BCNY438.36M · vs all stocks (USD)
Revenue per Share (TTM)
3.77CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-7.80%Gross Profit (TTM)
992.09MCNY148.15M · vs all stocks (USD)
EBITDA (TTM)
350.47MCNY52.34M · vs all stocks (USD)
Net Income (TTM)
20.53MCNY3.07M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-21.00%Operating Cash Flow (TTM)
588.60MCNY87.90M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
79.55MCNY11.88M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1000CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.89%vs all stocks
5-Year Average Dividend Yield
2.53%vs all stocks
Payout Ratio
374.53%Minority Interest (Equity)
214.94MCNYFY2025 · Dec 31, 2025Revenue
2.88BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.90BCNYFY2025 · Dec 31, 2025Gross Profit
974.50MCNYFY2025 · Dec 31, 2025Operating Income
337.96MCNY50.47M · vs all stocks (USD)
Pre-tax Income
39.15MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.13MCNYFY2025 · Dec 31, 2025Net Income
-10.98MCNYFY2025 · Dec 31, 2025EBIT
125.25MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
564.63MCNYFY2025 · Dec 31, 2025Research & Development
116.55MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
186.13MCNYFY2025 · Dec 31, 2025Other Operating Expenses
48.53MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
8.16MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
86.11MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.0353CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.0353CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
780.64MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
780.64MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-10.98MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
38.54MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
84.99MCNYFY2025 · Dec 31, 2025Free Cash Flow
-233.95MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
615.08MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-10.98MCNYFY2025 · Dec 31, 2025Other Non-cash Items
96.40MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
806.25KCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.23MCNYFY2025 · Dec 31, 2025Capital Expenditures
-318.95MCNYFY2025 · Dec 31, 2025Sale of Investments
349.50KCNYFY2025 · Dec 31, 2025Other Investing Activity
4.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-314.60MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.42BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.43BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-147.85MCNYFY2025 · Dec 31, 2025Other Financing Charges
33.22MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-123.52MCNYFY2025 · Dec 31, 2025Shares Outstanding
769.50MSharesUpdated Sep 21, 2026Float Shares
478.72MSharesUpdated Sep 21, 2026% Held by Insiders
34.50%vs all stocks
% Held by Institutions
1.88%vs all stocks
Total Cash (MRQ)
701.07MCNY104.69M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.9280CNYUpdated Sep 21, 2026Total Debt (MRQ)
2.50BCNY372.75M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.00xCurrent Ratio (MRQ)
1.18xBook Value per Share (MRQ)
3.00CNYUpdated Sep 21, 2026Total Assets
5.52BCNY824.14M · vs all stocks (USD)
Total Current Assets
2.06BCNYFY2025 · Dec 31, 2025Total Liabilities
3.08BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.46BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.27BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.80BCNYFY2025 · Dec 31, 2025Cash
615.08MCNYFY2025 · Dec 31, 2025Cash Equivalents
3.28MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
618.35MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.38MCNYFY2025 · Dec 31, 2025Accounts Receivable
534.76MCNYFY2025 · Dec 31, 2025Inventory
668.10MCNYFY2025 · Dec 31, 2025Accounts Payable
298.57MCNYFY2025 · Dec 31, 2025Short-term Debt
1.31BCNYFY2025 · Dec 31, 2025Other Current Liabilities
24.55MCNYFY2025 · Dec 31, 2025Long-term Debt
1.01BCNYFY2025 · Dec 31, 2025Common Stock (Book)
769.53MCNYFY2025 · Dec 31, 2025Retained Earnings
529.59MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.44BCNY364.86M · vs all stocks (USD)
Treasury Stock
94.28MCNYFY2025 · Dec 31, 202552-Week Low
4.58CNYUpdated Sep 21, 202652-Week High
7.24CNYUpdated Sep 21, 202652-Week Change
-21.81%vs all stocks
Beta
0.3340xvs all stocks
50-Day MA
5.16CNYUpdated Sep 21, 2026200-Day MA
5.68CNYUpdated Sep 21, 2026Avg 10-Day Volume
11.10MSharesUpdated Sep 21, 2026Avg 30-Day Volume
11.30MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.0300CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Dividend several times the last twelve months' earningsSignificant
Payout Ratio: 3.75Dividend per Share: 0.10Earnings per Share: 0.03
High gross margins eroded by operating costsNotable
Gross Margin: 0.40Profit Margin: 0.01
Financial Health
Altman Z-Score 1.65: grey zoneSignificant
Altman Z-Score: 1.65
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nuvectis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Shengnuo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Lianhuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Kinetic Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zevra Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Fuan Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Xiangxue Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule